← Eichor
Study identifier: NCT06883357 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

The Effects of Home-based Graded Repetitive Arm Supplementary Program Group on Stroke.

Condition: Stroke  ·  Sponsor: National Taiwan University Hospital

PhaseNA
Planned participants52
Who can joinAll sexes, 20 Years to no upper limit
Healthy volunteersNo

About this study

Graded repetitive arm supplementary program (GRASP) is a self administrated, home-based rehabilitation program and has been incorporated in Canadian Stroke Best Practice Recommendations. Past studies indicated that the home-based GRASP program could facilitate the motor function and motor recovery and prevent learned nonuse of affected upper limb of stroke patients. There is lacking of research and application of the home-based GRASP program in Taiwan. Therefore, this study aims to explore the effects of the home-based GRASP program, which is mainly executed in the form of group intervention, on the affected upper limb of stroke patients.

This description comes directly from the study's public registry record.

Talk to the study team

Chia-Yi Lin  ·  +886-3-5326151#523509  ·  G04812@hch.gov.tw

Always discuss trial participation with your own doctor first.

Locations (1)

National Taiwan University Hospital Hsin-Chu BranchHsinchu, TaiwanRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06883357